InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Payne Joseph E, Director. Officer active across 1 companies, notably Vallon Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Total volume traded: €67k. The latest transaction was disclosed on 25 May 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€33,63110,700 shares@ €3.1431100.0% of flow
Common Stock
SEC:0001104659-21-073495·
Ideal exit: 19 Feb 2022 (T+270)
€33,63110,700 shares@ €3.143150.0% of flow
Common Stock
SEC:0001104659-21-073495:0·
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Payne Joseph E
Joseph E. Payne is a Board Member at Vallon Pharmaceuticals, Inc. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for substance use disorders. With significant experience in the pharmaceutical sector, he plays a key role in strategic decisions and governance of the company.
